Traditionally, the life science real estate industry has been defined by the convergence of science, medicine, and commercialization in global efforts to improve human health. With the completion of the Human Genome Project in 2003, the growth in this segment of life sciences has accelerated with a strong emphasis on Precision Medicine, targeted personalized cancer treatment, and Precision Wellness. All of these areas combine a focus on genomics and biology with other technologies such as wearable technologies, big data, and artificial intelligence.
With a rich history of research and pharmaceutical development, Philadelphia is poised to be a leader in this field. From the early beginnings in 1740, with the establishment of the University of Pennsylvania through the development of major pharma companies like Merck in the 1800s, the region has grown with the life science industry and amassed a deep and educated labor pool. Today, the area is home to six medical schools, including four NCI-designated cancer centers, and the top-rated Children’s Hospital in the U.S. – Children’s Hospital of Philadelphia. 100+ colleges and universities are located within 50 miles of Philadelphia, 80% of all pharmaceutical and biotech companies have offices in Greater Philly, and more than 2,000 medical technology companies are located here.
For more information and to register, visit the Philly Builds Bio+ website.